Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
9.85
+0.12 (1.23%)
Aug 11, 2025, 1:17 PM - Market open
Paramount Global Employees
Niagen Bioscience had 104 employees as of December 31, 2024. The number of employees decreased by 2 or -1.89% compared to the previous year.
Employees
104
Change (1Y)
-2
Growth (1Y)
-1.89%
Revenue / Employee
$1,118,298
Profits / Employee
$170,471
Market Cap
787.21M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 104 | -2 | -1.89% |
Dec 31, 2023 | 106 | -7 | -6.19% |
Dec 31, 2022 | 113 | -2 | -1.74% |
Dec 31, 2021 | 115 | 5 | 4.55% |
Dec 31, 2020 | 110 | 0 | - |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jan 2, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
NAGE News
- 4 days ago - Niagen Bioscience, Inc. Reports Second Quarter 2025 Financial Results and Increases Full Year Outlook - Business Wire
- 7 days ago - Niagen Bioscience to Present at Canaccord Genuity's 45th Annual Growth Conference - Business Wire
- 19 days ago - Niagen Bioscience to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025 - Business Wire
- 4 weeks ago - Niagen Bioscience Announces the Debut of Tru Niagen® and Niagen IV at Equinox Hotel New York - Business Wire
- 4 weeks ago - Niagen Bioscience Secures Exclusive License to Develop and Commercialize its NAD+ Precursor, Patented Nicotinamide Riboside (Niagen®), as a Potential Parkinson's Disease Therapy in Agreement with Haukeland University Hospital in Bergen, Norway - Business Wire
- 6 weeks ago - Niagen Biosciences: Anti-Aging Market Leader And Prime Beneficiary Of Long-Term Demographic Trends - Seeking Alpha
- 7 weeks ago - Niagen Bioscience to Participate at the Roth 15th Annual London Conference - Business Wire
- 2 months ago - Niagen Bioscience to Participate in the BIO 2025 International Convention - Business Wire